Tanguy Seiwert
University of Chicago Comprehensive Cancer Center
3
3
2
N/A
0
5
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (3)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Anurag Singh
Roswell Park Cancer Institute
Shared therapeutic areas:
Worked with same sponsors:
Vassiliki Papadimitrakopoulou
SWOG Cancer Research Network
Shared therapeutic areas:
Worked with same sponsors:
Rebecca Schnall, PhD, MPH
Columbia University
Shared therapeutic areas:
Worked with same sponsors:
Novartis Vaccines and Diagnostics
Novartis
Shared therapeutic areas:
Worked with same sponsors:
Vincent Chung
City of Hope Medical Center
Shared therapeutic areas:
Worked with same sponsors:
Jennifer Tang, MD
UNC Lineberger Comprehensive Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Vikrant Sahasrabuddhe, MBBS, MPH, DrPH
Division of Cancer Prevention (DCP), NCI
Shared therapeutic areas:
Worked with same sponsors:
Nina Bhardwaj, MD, PhD
Icahn School of Medicine at Mount Sinai
Shared therapeutic areas:
Worked with same sponsors:
Gaetano Isola
University of Catania
Shared therapeutic areas:
Lameck Chinula, MD
University of North Carolina, Chapel Hill
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (3)
Showing 3 of 3 trials
BGJ398 in Treating Patients With FGFR Positive Recurrent Head and Neck Cancer
Cetuximab With or Without Tivantinib in Treating Patients With Head and Neck Cancer That Is Recurrent, Metastatic, or Cannot Be Removed by Surgery
PI3K Inhibitor BKM120 and Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
All 3 trials loaded